Andrei N. Tsentsevitsky

Andrei N. Tsentsevitsky

Auto-generated profile, based on publicly available information

Andrei N. Tsentsevitsky

Laboratory of biophysics of synaptic processes, Kazan Institute of Biochemistry and Biophysics, FRC Kazan Scientific Center of RAS, Kazan, Russia

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EBEllya Bukharaeva
Ellya Bukharaeva
VKVenera Khuzakhmetova
Venera Khuzakhmetova
SDSvetlana Anatolievna Dmitrieva
Svetlana Anatolievna Dmitrieva
ATAndrei Tsentsevitsky
Andrei Tsentsevitsky
Adrenoceptor activators and blockers are widely used clinically for the treatment of cardiovascular and pulmonary disorders. More recently, adrenergic agents have also been used to treat neurodegenerative diseases. Recent studies indicate a location of sympathetic varicosities in close proximity to neuromuscular junctions. The pressing question is whether there could be any effects of endo- or exogenous catecholamines on cholinergic neuromuscular transmission. It was shown that the pharmacological stimulation of adrenoceptors, as well as sympathectomy, can affect both acetylcholine release from motor nerve terminals and the functioning of postsynaptic acetylcholine receptors. In this review, we discuss the recent data regarding the effects of adrenergic drugs on neurotransmission at the neuromuscular junction. The elucidation of the molecular mechanisms by which the clinically relevant adrenomimetics and adrenoblockers regulate quantal acetylcholine release from the presynaptic nerve terminals and postsynaptic sensitivity may help in the design of highly effective and well-tolerated sympathomimetics for treating a number of neurodegenerative diseases accompanied by synaptic defects.

Verified
Journal Article
Open access
PDF file
ATAndrei N. Tsentsevitsky
Andrei N. Tsentsevitsky
GSGuzel Sibgatullina
Guzel Sibgatullina
YOYulia G. Odoshivkina
Yulia G. Odoshivkina
VKVenera F. Khuzakhmetova
Venera F. Khuzakhmetova
ATAnna R. Tokmakova
Anna R. Tokmakova
EBEllya Bukharaeva
Ellya Bukharaeva
Age-related impairment of the diaphragm causes respiratory complications. Neuromuscular junction (NMJ) dysfunction can be one of the triggering events in diaphragm weaknesses in old age. Prominent structural and functional alterations in diaphragm NMJs were described in elderly rodents, but NMJ changes in middle age remain unclear. Here, we compared diaphragm muscles from young adult (3 months) and middle-aged (12 months) BALB/c mice. Microelectrode recordings, immunofluorescent staining, electron microscopy, myography, and whole-body plethysmography were used. We revealed presynaptic (i) and postsynaptic (ii) changes. The former (i) included an increase in both action potential propagation velocity and neurotransmitter release evoked by low-, moderate-, and high-frequency activity but a decrease in immunoexpression of synapsin 1 and synaptic vesicle clustering. The latter (ii) consisted of a decrease in currents via nicotinic acetylcholine receptors and the area of their distribution. These NMJ changes correlated with increased contractile responses to moderate- to high-frequency nerve activation. Additionally, we found alterations in the pattern of respiration (an increase in peak inspiratory flow and a tendency of elevation of the tidal volume), which imply increased diaphragm activity in middle-aged mice. We conclude that enhancement of neuromuscular communication (due to presynaptic mechanism) accompanied by improved contractile responses occurs in the diaphragm in early aging.

7 October 2010 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
IKIrina V. Kovyazina
Irina V. Kovyazina
ATAndrei N. Tsentsevitsky
Andrei N. Tsentsevitsky
ENEvgeny E. Nikolsky
Evgeny E. Nikolsky
EBEllya Bukharaeva
Ellya Bukharaeva

20 November 2024 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
ATAndrei N. Tsentsevitsky
Andrei N. Tsentsevitsky
GSGuzel Sibgatullina
Guzel Sibgatullina
APAlexey Petrov
Alexey Petrov
AMArtem Malomouzh
Artem Malomouzh
IKIrina V. Kovyazina
Irina V. Kovyazina

1 April 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
ATAndrei N. Tsentsevitsky
Andrei N. Tsentsevitsky
GZGuzalia F. Zakyrjanova
Guzalia F. Zakyrjanova
APAlexey Petrov
Alexey Petrov
IKIrina V. Kovyazina
Irina V. Kovyazina

15 June 2018 in Acta Naturae
Verified
Journal Article
Open access
EKE. F. Khaziev
E. F. Khaziev
DSD. V. Samigullin
D. V. Samigullin
ATA. N. Tsentsevitsky
A. N. Tsentsevitsky
EBE. A. Bukharaeva
E. A. Bukharaeva
ENE. E. Nikolsky
E. E. Nikolsky
At neuromuscular junctions, ATP inhibits both the evoked and spontaneous acetylcholine release and inward calcium current operating via presynaptic P2Y receptors. It was shown in the experiments with the frog neuromuscular synapse using specific calcium-sensitive dye Oregon Green Bapta 1 that exogenous ATP reduces the amplitude of calcium transient, which reflects the changes in the entry of calcium ions in response to the nerve pulse. The depressing effect of ATP on the transient was prevented by suramin, the blocker of P2 receptors. Nitrendipine, a specific blocker of L-type calcium channels, per se decreased the calcium transient amplitude and significantly attenuated the effect of ATP on the calcium signal. Contrariwise, the preliminary application of ATP to the neuromuscular junction completely eliminated the depressing effect of nitrendipine on the calcium response. The obtained data suggest that an essential component in the inhibitory action of ATP on the calcium transient amplitude is provided by reduction of the entry of calcium ions into a frog nerve ending via L-type voltage-gated calcium channels.